Table 1.
ADL and IADL related life expectancy at age 65 by nativity, age at migration, and sex
ADL | IADL | |||||||
---|---|---|---|---|---|---|---|---|
|
||||||||
US-Born | 0–19 | 20–49 | 50+ | US-Born | 0–19 | 20–49 | 50+ | |
|
||||||||
Females | Years (CI) | Years (CI) | Years (CI) | Years (CI) | Years (CI) | Years (CI) | Years (CI) | Years (CI) |
TLE | 17.8 (17.1–18.4) | 20.8 (19.3–22.4)* | 18.9 (17.9–19.7) | 19.5 (17.8–21.1) | 17.8 (17.1–18.4) | 20.8 (19.3–22.4)* | 18.9 (17.9–19.7) | 19.5 (17.8–21.1) |
DFLE | 13.4 (12.9–14.0) | 15.6 (14.4–16.9)* | 14.2 (13.4–14.9) | 13.6 (12.2–14.8) | 7.1 (6.7–7.5) | 5.8 (4.8–6.0)* | 5.3 (4.5–5.7)* | 4.2 (3.4–5.1)* |
DLE | 4.3 (4.0–4.6) | 5.2 (4.4–6.0)* | 4.7 (4.1–5.2) | 5.9 (4.9–7.0)* | 10.7 (10.2–11.1) | 15.0 (13.4–16.6) * | 13.6 (12.9–14.4) * | 15.2 (13.7–16.9)* |
Ratio | 0.76 (0.74–0.77) | 0.75 (0.71–0.78) | 0.75 (0.73–0.78) | 0.70 (0.66–0.73)* | 0.40 (0.38–0.42) | 0.28 (0.24–0.33) * | 0.28 (0.25–0.32) * | 0.22 (0.18–0.26)* |
Males | ||||||||
TLE | 15.4 (14.8–16.1) | 16.0 (14.1–18.1) | 17.1 (16.2–18.4)* | 16.1 (14.3–17.8) | 15.4 (14.8–16.1) | 16.0 (14.1–18.1) | 17.1 (16.2–18.4)* | 16.1 (14.3–17.8) |
DFLE | 12.7 (12.1–13.3) | 13.2 (11.6–14.9) | 14.3 (13.4–15.2)* | 13.8 (13.4–15.3) * | 8.8 (8.3–9.3) | 9.5 (8.0–11.0) | 9.3 (8.3–10.2) | 8.2 (7.1–9.5) |
DLE | 2.8 (2.5–3.1) | 2.7 (2.1–3.6) | 2.8 (2.4–3.3) | 2.3 (1.7–2.9) | 6.6 (6.2–7.1) | 6.5 (5.4–7.8) | 7.9 (7.2–8.7)* | 8.0 (6.6–9.2)* |
Ratio | 0.82 (0.80–0.84) | 0.83 (0.79–0.86) | 0.83 (0.81–0.86) | 0.86 (0.83–0.89) | 0.57 (0.55–0.59) | 0.60 (0.54–0.64) | 0.54 (0.50–0.58) | 0.51 (0.45–0.57)* |
Source: HEPESE Wave 1–8 (1993–2013)
Note: CI = Confidence Intervals; TLE = Total Life Expectancy; DFLE = Disability-Free Life Expectancy; DLE = Disabled Life; Expectancy; Ratio = DFLE/TLE;
p<=0.05